Anne-Françoise Donneau

Anne-Françoise Donneau

Auto-generated profile, based on publicly available information

Anne-Françoise Donneau

Research Unit Public Health, From Biostatistics to Health Promotion, University of Liège, 4000 Liège, Belgium

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2015 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
MLMarc-Gilbert Lagny
Marc-Gilbert Lagny
FJFrançois Jouret
François Jouret
JKJean-Noël Koch
Jean-Noël Koch
FBFrancine Blaffart
Francine Blaffart
ADAnne-Françoise Donneau
Anne-Françoise Donneau
JDJean-Olivier Defraigne
Jean-Olivier Defraigne
Adult cardiac surgery is significantly associated with the development of acute kidney injury (AKI). Still, the incidence and outcomes of AKI vary according to its definition. Our retrospective monocentric study comparatively investigates the yield of RIFLE definition, which is based on the elevation of serum creatinine levels (SCr) or the reduction of urine output (UO), taking into account only one or both criteria. Pre- and per-operative risk factors for post-operative AKI were evaluated. All adult patients undergoing cardiac surgery, with or without cardiopulmonary bypass, from April 2008 to March 2009 were included. Clinical, biological and surgical features were recorded. Baseline serum creatinine was determined as its value on day 7 before surgery. Post-operative AKI was diagnosed and scored based upon the highest serum creatinine and/or the lowest urine output. 443 patients (Male/Female ratio, 2.3; median age, 69y) were included, with 221 (49.9 %) developing postoperative AKI. Elevated serum creatinine (AKISCr) and oliguria (AKIUO) was observed in 9.7 % and 40.2 %, respectively. AKI patients had a significantly higher BMI and baseline SCr. In comparison to AKIUO, AKISCr mostly occurred in patients with co-morbidities, and was associated with an increased mortality at 1-year post surgery. The use of standard RIFLE definition of AKI in a cohort of 443 patients undergoing cardiac surgery resulted in an incidence reaching 50 %. Still, significant discrepancies were found between AKISCr and AKIUO regarding the incidence and outcomes. In line with previous reports, our data questions the utility of urine output as a criterion for AKI diagnosis and management after cardiac surgery.

27 July 2019 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
YHYves Henrotin
Yves Henrotin
MMM. Malaise
M. Malaise
RWR. Wittoek
R. Wittoek
KVK. de Vlam
K. de Vlam
JBJ.-P. Brasseur
J.-P. Brasseur
YDY. Dierckxsens
Y. Dierckxsens
Comparison of two doses of bio-optimized Curcuma longa extract (BCL) in the management of symptomatic knee osteoarthritis (OA). A prospective, randomized, 3-month, double-blind, multicenter, three-group, placebo-controlled trial assessing Patient Global Assessment of Disease Activity (PGADA) and serum sColl2-1, a biomarker of cartilage degradation, as co-primary endpoints. Pain on visual analog scale (VAS), Knee injury and Osteoarthritis Outcome Score (KOOS), and paracetamol/non-steroidal anti-inflammatory drug (NSAID) consumption were used as secondary endpoints. One hundred fifty patients with knee OA were followed for 90 days. Low and high doses of BCL showed a greater decrease of PGADA than placebo. Analysis of sColl2-1 showed in the placebo and BCL low-dose groups, but not in the BCL high-dose group, a transient but non-significant increase of sColl2-1 between T0 and T1. Thereafter, in all groups, sColl2-1 decreased between T1 and T3 (all p < 0.01), but no difference between the groups was found. Pain reduction at day 90 in the low- and high-dose BCL groups (− 29.5 mm and − 36.5 mm) was higher than that in the placebo (− 8 mm; p = 0.018). The global KOOS significantly decreased overtime, but changes were comparable across treatment arms. The ratio of patients with adverse events (AE) related to the product was similar in the placebo and treatment groups, but the number of AE linked to the product was higher in the high-dose BCL group compared to the placebo (p = 0.012). BCL appeared safe and well-tolerated with no evidence of severe adverse effects. Efficacy analysis suggested positive trends for measurements of PGADA and serum levels of an OA biomarker and showed a rapid and significant decrease of pain in knee OA (Trial registration: NCT02909621, 21 September 2016 - retrospectively registered).

10 August 2010 in BMC Public Health
Verified
Journal Article
Open access
PDF file
AAAla'a Alkerwi
Ala'a Alkerwi
NSNicolas Sauvageot
Nicolas Sauvageot
ADAnne-Françoise Donneau
Anne-Françoise Donneau
MLMarie-Lise Lair
Marie-Lise Lair
SCSophie Couffignal
Sophie Couffignal
MGMichèle Guillaume
Michèle Guillaume
The ORISCAV-LUX study is the first baseline survey of an on-going cardiovascular health monitoring programme in Grand-Duchy of Luxembourg. The main objectives of the present manuscript were 1) to describe the study design and conduct, and 2) to present the salient outcomes of the study, in particular the prevalence of the potentially modifiable and treatable cardiovascular disease risk factors in the adult population residing in Luxembourg.

1 January 2015 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
MHMarie-Noëlle Horcajada
Marie-Noëlle Horcajada
Christelle SanchezChristelle Sanchez
Christelle Sanchez
FSF. Membrez Scalfo
F. Membrez Scalfo
PDP. Drion
P. Drion
FCF. Comblain
F. Comblain
YHYves Henrotin
Yves Henrotin

4 January 2011 in BMC Public Health
Verified
Journal Article
Open access
PDF file
AAAla'a Alkerwi
Ala'a Alkerwi
ADAnne-Françoise Donneau
Anne-Françoise Donneau
NSNicolas Sauvageot
Nicolas Sauvageot
MLMarie-Lise Lair
Marie-Lise Lair
ASAndré Scheen
André Scheen
MGMichèle Guillaume
Michèle Guillaume
The prevalence of the metabolic syndrome (MS) has been determined in many countries worldwide but never in Luxembourg. This research aimed to 1) establish the gender- and age-specific prevalence of MS and its components in the general adult population of Luxembourg, according to the most recent Joint Interim Statement (JIS) definition, by using both the high and low cut-off points to define abdominal obesity, and 2) compare and assess the degree of agreement with the Revised National Cholesterol Education Programme-Adult Treatment Panel III (R-ATPIII) and the International Diabetes Federation (IDF) definitions.

18 April 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
AHaxelle hoge
axelle hoge
VTValentine Tabar
Valentine Tabar
ADAnne-Françoise Donneau
Anne-Françoise Donneau
NDNadia Dardenne
Nadia Dardenne
SDSylvie Degée
Sylvie Degée
VCVincenzo Castronovo
Vincenzo Castronovo
While studies revealed that the omega-3 polyunsaturated fatty acids (n-3 PUFA) and their mediators would be able to regulate several biological processes involved into the development of postpartum depression (PPD), evidence from observational studies remains mixed. The aim of the present study was to investigate the association between maternal erythrocyte n-3 PUFA, measured in early pregnancy, and the risk of PPD. A Belgian cohort of 72 healthy women was screened. Erythrocyte fatty acids were analysed using gas chromatography. PPD was assessed using the Bromley Postnatal Depression Scale by phone interview one year after delivery. We observed a significant negative association between docosahexaenoic acid (DHA) levels and the risk of postpartum depression in the adjusted model (p = 0.034). Higher n-6/n-3 and arachidonic acid (AA)/eicosapentaenoic acid (EPA) ratios were significantly associated with an increased odds of PPD (p = 0.013 and p = 0.043, respectively). Women with an omega-3 index <5% had a 5-fold increased risk of depressive episode than did those with an omega-3 index ≥5% (OR 5.22 (95% CI 1.24–21.88)). A low n-3 PUFA status, alone and combined with high n-6 PUFA status, in early pregnancy was associated with a greater risk of PPD. Management of maternal n-3 PUFA deficiency can be a simple, safe and cost-effective strategy for the prevention of this major public health issue.